BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 19590184)

  • 1. Early diagnosis of acute kidney injury: the promise of novel biomarkers.
    Soni SS; Ronco C; Katz N; Cruz DN
    Blood Purif; 2009; 28(3):165-74. PubMed ID: 19590184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Performance neutrophil gelatinase-associated lipocalin in clinical settings].
    Gala-Bładzińska A; Kuzniewski M
    Przegl Lek; 2013; 70(6):400-3. PubMed ID: 24052978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury.
    Shemin D; Dworkin LD
    Crit Care Clin; 2011 Apr; 27(2):379-89. PubMed ID: 21440207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of acute kidney injury with neutrophil gelatinase-associated lipocalin.
    McCullough PA; El-Ghoroury M; Yamasaki H
    J Am Coll Cardiol; 2011 Apr; 57(17):1762-4. PubMed ID: 21511112
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.
    Vanmassenhove J; Vanholder R; Nagler E; Van Biesen W
    Nephrol Dial Transplant; 2013 Feb; 28(2):254-73. PubMed ID: 23115326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients.
    Matsa R; Ashley E; Sharma V; Walden AP; Keating L
    Crit Care; 2014 Jul; 18(4):R137. PubMed ID: 24985156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil gelatinase-associated lipocalin as a follow-up marker in critically ill pediatric patients with established acute kidney injury.
    Polat M; Fidan K; Derinöz O; Gönen S; Söylemezoglu O
    Ren Fail; 2013; 35(3):352-6. PubMed ID: 23391290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury.
    Dai X; Zeng Z; Fu C; Zhang S; Cai Y; Chen Z
    Crit Care; 2015 May; 19(1):223. PubMed ID: 25944130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility window for acute kidney injury biomarkers in the critically ill.
    Ralib AM; Pickering JW; Shaw GM; Than MP; George PM; Endre ZH
    Crit Care; 2014 Nov; 18(6):601. PubMed ID: 25366893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass.
    Tuladhar SM; Püntmann VO; Soni M; Punjabi PP; Bogle RG
    J Cardiovasc Pharmacol; 2009 Mar; 53(3):261-6. PubMed ID: 19247188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study.
    Di Nardo M; Ficarella A; Ricci Z; Luciano R; Stoppa F; Picardo S; Picca S; Muraca M; Cogo P
    Blood Purif; 2013; 35(1-3):172-6. PubMed ID: 23428967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.
    Devarajan P
    Biomark Med; 2010 Apr; 4(2):265-80. PubMed ID: 20406069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin: a novel biomarker in acute kidney injury.
    Carrillo-Esper R; Castillo-Albarrán FM; Pérez-Jáuregui J
    Cir Cir; 2011; 79(6):577-81. PubMed ID: 22169379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil gelatinase-associated lipocalin in acute kidney injury.
    Makris K; Kafkas N
    Adv Clin Chem; 2012; 58():141-91. PubMed ID: 22950345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of novel biomarkers in early diagnosis and prognosis of acute kidney injury in newborns.
    Argyri I; Xanthos T; Varsami M; Aroni F; Papalois A; Dontas I; Fanos V; Iacovidou N
    Am J Perinatol; 2013 May; 30(5):347-52. PubMed ID: 23023560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.
    Haase M; Devarajan P; Haase-Fielitz A; Bellomo R; Cruz DN; Wagener G; Krawczeski CD; Koyner JL; Murray P; Zappitelli M; Goldstein SL; Makris K; Ronco C; Martensson J; Martling CR; Venge P; Siew E; Ware LB; Ikizler TA; Mertens PR
    J Am Coll Cardiol; 2011 Apr; 57(17):1752-61. PubMed ID: 21511111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury].
    Abassi Z; Sagi O; Armaly Z; Bishara B
    Harefuah; 2011 Feb; 150(2):111-6, 207, 206. PubMed ID: 22164937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-GAL: diagnosing AKI as soon as possible.
    Ronco C
    Crit Care; 2007; 11(6):173. PubMed ID: 18001501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute kidney injury in critically ill infants: the role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL).
    Mussap M; Degrandi R; Fravega M; Fanos V
    J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():70-2. PubMed ID: 20807163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.